BEBTELOVIMAB

Manufacturer:

Eli Lilly and Company

Name:

BEBTELOVIMAB

HCPCS Code Descriptor:

Injection, bebtelovimab, 175 mg

Category:

Q Code

HCPCS:

Q0222

NDC(s):

00002-7589-01

Primary Type:

COVID-19

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00002-7589-01

About:

BEBTELOVIMAB is a COVID-19 drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The Q Code: Q0222 is aligned to the drug BEBTELOVIMAB.